| GO | Name |
| GO:0000187 | obsolete activation of MAPK activity |
| GO:0001558 | regulation of cell growth |
| GO:0001819 | positive regulation of cytokine production |
| GO:0001822 | kidney development |
| GO:0001974 | blood vessel remodeling |
| GO:0002016 | regulation of blood volume by renin-angiotensin |
| GO:0002018 | renin-angiotensin regulation of aldosterone production |
| GO:0002019 | regulation of renal output by angiotensin |
| GO:0002034 | maintenance of blood vessel diameter homeostasis by renin-angiotensin |
| GO:0003014 | renal system process |
| GO:0004867 | serine-type endopeptidase inhibitor activity |
| GO:0005179 | hormone activity |
| GO:0005576 | extracellular region |
| GO:0005615 | extracellular space |
| GO:0005829 | cytosol |
| GO:0007186 | G protein-coupled receptor signaling pathway |
| GO:0007199 | G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger |
| GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0007263 | nitric oxide mediated signal transduction |
| GO:0007267 | cell-cell signaling |
| GO:0008083 | growth factor activity |
| GO:0008217 | regulation of blood pressure |
| GO:0010536 | positive regulation of activation of Janus kinase activity |
| GO:0010595 | positive regulation of endothelial cell migration |
| GO:0010613 | positive regulation of cardiac muscle hypertrophy |
| GO:0010629 | negative regulation of gene expression |
| GO:0010744 | positive regulation of macrophage derived foam cell differentiation |
| GO:0010873 | positive regulation of cholesterol esterification |
| GO:0010951 | negative regulation of endopeptidase activity |
| GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0014873 | response to muscle activity involved in regulation of muscle adaptation |
| GO:0016176 | superoxide-generating NADPH oxidase activator activity |
| GO:0017080 | sodium channel regulator activity |
| GO:0019222 | regulation of metabolic process |
| GO:0019229 | regulation of vasoconstriction |
| GO:0031702 | type 1 angiotensin receptor binding |
| GO:0031703 | type 2 angiotensin receptor binding |
| GO:0032270 | positive regulation of cellular protein metabolic process |
| GO:0033864 | positive regulation of NAD(P)H oxidase activity |
| GO:0034374 | low-density lipoprotein particle remodeling |
| GO:0035813 | regulation of renal sodium excretion |
| GO:0038166 | angiotensin-activated signaling pathway |
| GO:0042127 | regulation of cell population proliferation |
| GO:0042310 | vasoconstriction |
| GO:0043407 | negative regulation of MAP kinase activity |
| GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0045893 | positive regulation of transcription, DNA-templated |
| GO:0048018 | receptor ligand activity |
| GO:0048146 | positive regulation of fibroblast proliferation |
| GO:0050729 | positive regulation of inflammatory response |
| GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0051092 | positive regulation of NF-kappaB transcription factor activity |
| GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway |
| GO:0061098 | positive regulation of protein tyrosine kinase activity |
| GO:0062023 | collagen-containing extracellular matrix |
| GO:0070062 | extracellular exosome |
| GO:0072562 | blood microparticle |
| GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:1901201 | regulation of extracellular matrix assembly |
| GO:1902632 | positive regulation of membrane hyperpolarization |
| GO:1903598 | positive regulation of gap junction assembly |
| GO:1903779 | regulation of cardiac conduction |
| GO:2000379 | positive regulation of reactive oxygen species metabolic process |
| GO:2000650 | negative regulation of sodium ion transmembrane transporter activity |
| GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway |